Observational analysis reveals secondary primary malignancy risks in indolent non-Hodgkin lymphoma patients, suggesting further investigation is needed.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Davies et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: